Science ❯ Biotechnology

Immunology

Vaccine Research Allergen Research Cancer Immunotherapy Vaccine Development Autoimmune Disorders Inflammation Antibodies Antibody Engineering Healthcare Therapeutic Antibodies Vaccine Technology Therapeutics Cell Therapy Antibody Research Toll-like Receptors Immune Response

PROTEXI Vaccine Redirects COVID‑19 Immune Memory to Target Tumors

A peer‑reviewed preclinical study reports stronger tumor‑specific T‑cell responses and has prompted plans for a first‑in‑human sarcoma trial.

AI-Designed 'Super‑Antigen' Vaccine Clears First Human Test

AI-Designed 'Super‑Antigen' Vaccine Passes Phase I Safety Test

DNA Origami Vaccine Scaffold Sharply Focuses HIV Immune Response in Preclinical Study

Lilly, Repertoire Strike Up-to-$1.93 Billion Autoimmune Drug Pact

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Biogen Licenses Vanqua’s Preclinical C5aR1 Drug in Deal Worth Up to $1.06 Billion

Intranasal Antibody Cuts Mugwort Allergy in Mice, Paving Way for Human Trials

Leukemia-on-a-Chip Enables Rapid, Scalable CAR T-Cell Therapy Screening